Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UK's Latest Cancer Drug Cull Draws Renewed Calls For NICE Reform

This article was originally published in The Pink Sheet Daily

Executive Summary

New cuts to publicly funded British NHS oncology treatments trigger fresh criticisms of the government's Cancer Drugs Fund and renewed calls for a system-wide overhaul of the way cancer drugs are commissioned in the country. Roche CEO suggests company may opt out of conducting trials in UK.

Advertisement

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

PS078984

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Add a personalized Question to your Analyst

Cancel